# Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant

> **NCT03960801** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 1150 (actual)

## Conditions studied

- Intra-tracheal Intubation

## Interventions

- **DRUG:** Remifentanil group
- **DRUG:** neuromuscular blockade group

## Key facts

- **NCT ID:** NCT03960801
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-09
- **Primary completion:** 2021-04-22
- **Final completion:** 2021-04-22
- **Target enrollment:** 1150 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960801, "Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03960801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*